Evidence map›Paper›PMID 31864342›Full record

ArticleBMC pulmonary medicine2019

Vitamin D deficiency among patients with pulmonary hypertension.

Andrés N Atamañuk, Diego F Litewka, Sergio J Baratta, Ignacio M Seropian, Graciela Perez Prados, Miguel O Payaslian, Juan P Ortiz Fragola, Pilar Escribano Subias

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Understanding the Role of Vitamin D in Heart Failure.Reviews in cardiovascular medicine · 2023
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Andrés N AtamañukDivisión Cardiología y Servicio de Neumonología, Hospital General de Agudos "Juan A. Fernández", Ciudad Autónoma de Buenos Aires, Argentina. aatamanu@cas.austral.edu.ar.
Diego F LitewkaDivisión Cardiología y Servicio de Neumonología, Hospital General de Agudos "Juan A. Fernández", Ciudad Autónoma de Buenos Aires, Argentina.
Sergio J BarattaInstituto de Cardiología y Terapéutica Cardiovascular, Hospital Universitario Austral, Buenos Aires, Argentina.
Ignacio M SeropianServicio de Hemodinamia, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Graciela Perez PradosDivisión Cardiología y Servicio de Neumonología, Hospital General de Agudos "Juan A. Fernández", Ciudad Autónoma de Buenos Aires, Argentina.
Miguel O PayaslianDivisión Cardiología y Servicio de Neumonología, Hospital General de Agudos "Juan A. Fernández", Ciudad Autónoma de Buenos Aires, Argentina.
Juan P Ortiz FragolaDivisión Cardiología y Servicio de Neumonología, Hospital General de Agudos "Juan A. Fernández", Ciudad Autónoma de Buenos Aires, Argentina.
Pilar Escribano SubiasServicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid, Spain.
Hospital Fernández · ARHospital Italiano de Buenos Aires · ARHospital Universitario 12 De Octubre · ESHospital Universitario Austral · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is little information about vitamin D (Vit D) deficiency in patients with pulmonary hypertension (PH). The objective of this study was: 1) compare Vit D levels between patients with PH, left ventricular failure (LVF) and healthy subjects (HS); 2) correlate, in patients with PH, Vit D levels with prognosis-related variables, such as the 6-min walk test (6MWT).

methodsVitamin D levels were measured in a cross-sectional study in 126 patients from one of three groups: patients with PH (n = 53), patients with LVF (n = 42) and healthy subjects (n = 31). In all groups, 8-h fasting blood samples were obtained in the morning. In the PH and the LVF group, functional class (WHO criteria), metres covered in the 6MWT and echocardiographic parameters were analysed. In the PH group, plasma N terminal pro B type natriuretic peptide (NT-proBNP) level was analysed and a complete haemodynamic evaluation by right heart catheterisation was made.

resultsMean Vit D levels were lower in PH than in both other groups (ng/ml, mean ± SD): PH 19.25 ± 10, LVF 25.68 ± 12, HS 28.8 ± 12 (PH vs LVF p = 0.017, PH vs HS p = 0.001 and HS vs LVF p = 0.46). Vit D deficiency prevalence was higher in PH as compared to the other groups (PH 53.8%, LVF 45.2%, HS 25%, p = 0.01). Patients with PH in functional class (FC; WHO criteria) III-IV had higher Vit D deficiency prevalence than those in FC I-II (86.7% vs 40.5%, p = 0.003). There was a significant linear correlation between the 6MWT and Vit D levels in PH (p < 0.01), but not in LVF (p = 0.69).

conclusionsVit D levels were lower in patients with PH as compared to patients with LVF and HS and correlated directly with 6-min walk distance.

Indexed as

AdultAgedCase-Control StudiesCross-Sectional StudiesEchocardiographyFemaleHeart FailureHumansHypertension, PulmonaryMaleMiddle AgedNatriuretic Peptide, BrainPeptide FragmentsPrevalencePrognosisVentricular Dysfunction, Left25-hydroxyvitamin DNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Vitamin DPulmonary arterial hypertensionPulmonary hypertensionVitamin DVitamin deficiency

Identifiers

PMID31864342
PMCPMC6925472
OpenAlexW2995344921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.